Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 18 lat
- •Podpisana zgoda na udział w badaniu
- •Potwierdzony histologicznie rak gruczołowy prostaty, który nie był wcześniej leczony
- •Rak prostaty wysokiego ryzyka (zaawansowany guz, wysoki stopień złośliwości lub podwyższony PSA powyżej 20)
- •Pacjent zdecydował się na operację usunięcia prostaty z usunięciem węzłów chłonnych
✗ Disqualifies
- •Przyjęcie radioaktywnego leku w ciągu 5 okresów półtrwania przed badaniem
- •Znana uczulenie na 64Cu-SAR-bisPSMA lub jego składniki
- •Rak prostaty typu małokomórkowego lub neuroendokrynnego
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 11, 2026
- Sex
- Male only
Therapies / drugs in trial
Locations (34)
University of Alabama Birmingham Hospital
Birmingham, United States
Mayo Clinic- Phoenix
Phoenix, United States
Arkansas Urology Research Center, LLC
Little Rock, United States
Urology Group of Southern California
Los Angeles, United States
Greater Los Angeles VA Medical Center
Los Angeles, United States
UC Irvine Health
Orange, United States
Stanford University Medical Center
Stanford, United States
Mayo Clinic- Jacksonville
Jacksonville, United States
Biogenix Molecular, LLC
Miami, United States
NorthShore University Health System, Glenbrook Hospital
Glenview, United States
Indiana University School of Medicine
Indianapolis, United States
Wichita Urology Group
Wichita, United States
BAMF Health
Grand Rapids, United States
Corewell Health
Grand Rapids, United States
Mayo Clinic- Rochester
Rochester, United States
XCancer Omaha LLC
Omaha, United States
Albany Medical College, Department of Urology
Albany, United States
Mount Sinai Doctors Urology Faculty Practice
New York, United States
Duke University Medical Center
Durham, United States
Urologic Specialists
Tulsa, United States
Oregon Urology
Springfield, United States
Carolina Urologic Research Center
Myrtle Beach, United States
Urology Associates of Nashville
Nashville, United States
Urology Austin, PLLC - Research Department
Austin, United States
Urology Clinics of North Texas
Dallas, United States
University of Texas Southwestern Medical Center
Dallas, United States
The Urology Place
San Antonio, United States
Intermountain Health
Murray, United States
University of Wisconsin
Madison, United States
St. Vincent's Sydney
Sydney, Australia
Princess Alexandra Hospital
Woolloongabba, Australia
Fiona Stanley Hospital
Murdoch, Australia
RAMSAY HEALTH CARE AUSTRALIA PTY LIMITED (ABN 36 003 184 889) trading as Hollywood Private Hospital
Nedlands, Australia
Pan American Center for Oncology Trials, LLC - Ciudadela
San Juan, Puerto Rico
Trial contact
Clarity Pharmaceuticals
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/12/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.